Amino acid sequence and inhibitory activity of rhesus monkey tissue factor pathway inhibitor (TFPI): comparison with human TFPI.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of Biochemistry (Tokyo)

• Publication date

  1994-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/OXFORDJOURNALS.JBCHEM.A124400PMID 8089087
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa.

  1992cited by this paper
• cDNA cloning and expression of rat tissue factor pathway inhibitor (TFPI).

  1992cited by this paper
• The effect of leukocyte elastase on tissue factor pathway inhibitor.

  1992cited by this paper
• Purification of tissue factor pathway inhibitor (TFPI) from rabbit plasma and characterization of its differences from TFPI isolated from human plasma.

  1992cited by this paper
• The present status of tissue factor pathway inhibitor.

  1992cited by this paper
• Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: evidence supporting a physiologic role for EPI as a natural anticoagulant.

  1991cited by this paper
• Treatment with hydroxymethylglutaryl-coenzyme A reductase inhibitors in hypercholesterolemia induces changes in the components of the extrinsic coagulation system.

  1991cited by this paper
• The Extrinsic Pathway Inhibitor: A Regulator of Tissue Factor-Dependent Blood Coagulation

  1991cited by this paper
• Immunodepletion of extrinsic pathway inhibitor sensitizes rabbits to endotoxin-induced intravascular coagulation and the generalized Shwartzman reaction.

  1991cited by this paper
• cDNA sequence of rabbit lipoprotein-associated coagulation inhibitor.

  1990cited by this paper
• Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions.

  1990cited by this paper
• Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains.

  1988cited by this paper
• Automated fluorogenic methods for the evaluation of the extrinsic coagulation reactions in human plasma.

  1988cited by this paper
• Effect of gamma rays at the dihydrofolate reductase locus: Deletions and inversions

  1986cited by this paper
• A simplified procedure for purification of human prothrombin, factor IX and factor X.

  1981cited by this paper
• The graphical determination of K m and K i .

  1972cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• New insights into the clearance of tissue factor pathway inhibitor (TFPI) and unfractionated heparin (UFH)

  2010cites this paper
• Tissue factor pathway inhibitor is highly susceptible to chymase‐mediated proteolysis

  2007cites this paper
• Tissue factor pathway inhibitor: structure, biology and involvement in disease

  2006cites this paper
• A novel therapeutic approach combining human plasma‐derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa alone

  2003cites this paper
• Tissue factor pathway inhibitor is highly susceptible to chymase-mediated proteolysis.

  2003cites this paper
• Increased Plasma Thrombomodulin as a Vascular Endothelial Cell Marker in Patients With Thrombotic Thrombocytopenic Purpura and Hemolytic Uremic Syndrome

  2001cites this paper
• Recombinant Tissue Factor Pathway Inhibitor Prevents Lipopolysaccharide-induced Systemic Hypotension in Rats by Inhibiting Excessive Production of Nitric Oxide

  2001cites this paper
• Recombinant tissue factor pathway inhibitor reduces lipopolysaccharide-induced pulmonary vascular injury by inhibiting leukocyte activation.

  2000influential citation
• The effect of heparin on tissue factor and tissue factor pathway inhibitor in patients with acute myocardial infarction.

  2000cites this paper
• Hemostatic Abnormalities in Patients With Thrombotic Complications on Maintenance Hemodialysis

  2000cites this paper
• Altered Plasma Antigen Levels of Tissue Factor Pathway Inhibitor During Open-Heart Surgery

  2000cites this paper
• Purification and Characterization of Factor VII Inhibitor Found in a Patient with Life Threatening Bleeding

  2000cites this paper
• TFPIβ, a Second Product from the Mouse Tissue Factor Pathway Inhibitor (TFPI) Gene

  1999cites this paper
• Polymorphisms of the tissue factor pathway inhibitor (TFPI) gene in patients with acute coronary syndromes and in healthy subjects : impact of the V264M substitution on plasma levels of TFPI.

  1999cites this paper
• Changes of plasma hemostatic markers during percutaneous transluminal coronary angioplasty in patients with chronic coronary artery disease

  1999cites this paper
• Deranged blood coagulation equilibrium as a factor of massive liver necrosis following endotoxin administration in partially hepatectomized rats

  1999cites this paper
• Adenovirus-mediated local expression of human tissue factor pathway inhibitor eliminates shear stress-induced recurrent thrombosis in the injured carotid artery of the rabbit.

  1999cites this paper
• Monkey hepatocytes efficiently express tissue factor pathway inhibitor (TFPI), in contrast with human and rat hepatocytes.

  1999cites this paper
• Plasma tissue factor pathway inhibitor and tissue factor antigen levels after administration of heparin in patients with angina pectoris.

  1999cites this paper
• Circadian variation in plasma levels of free-form tissue factor pathway inhibitor antigen in patients with coronary spastic angina.

  1998cites this paper
• Human recombinant tissue factor pathway inhibitor induces apoptosis in cultured human endothelial cells

  1998cites this paper
• Heparin-releasable endothelial cell-associated tissue factor pathway inhibitor (TFPI) is increased in the coronary circulation after coronary spasm in patients with coronary spastic angina.

  1998cites this paper
• Changes in plasma tissue factor pathway inhibitor levels during the clinical course of disseminated intravascular coagulation

  1998cites this paper
• Cloning, Expression, and Characterization of Mouse Tissue Factor Pathway Inhibitor (TFPI)

  1998cites this paper
• A kinetic analysis of the interaction of human recombinant tissue factor pathway inhibitor with factor Xa utilizing and immunoassay and the effect of antithrombin III/heparin on the complex formation.

  1998cites this paper
• Human recombinant tissue‐factor pathway inhibitor prevents the proliferation of cultured human neonatal aortic smooth muscle cells

  1997cites this paper
• Effect of Depolymerized Holothurian Glycosaminoglycan (DHG) on Tissue Factor Pathway Inhibitor: In Vitro and In Vivo Studies

  1997cites this paper
• Increased tissue factor pathway inhibitor in patients with acute myocardial infarction

  1997cites this paper
• Recombinant human tissue factor pathway inhibitor as a possible anticoagulant targeting hepatic sinusoidal walls.

  1997cites this paper
• Effect of porcine endothelial tissue factor pathway inhibitor on human coagulation factors.

  1997cites this paper
• Cloning of the cDNA Encoding Mouse PP5/TFPI-2 and Mapping of the Gene to Chromosome 6

  1996cites this paper
• Pharmacologic Studies on Synthetic Analogues of Heparin with Selective Affinity to Endogenous Serine Protease Inhibitors

  1996cites this paper
• Effects of recombinant human tissue factor pathway inhibitor on thrombus formation and its in vivo distribution in a rat DIC model.

  1996cites this paper
• The clearance of proteoglycan-associated human recombinant tissue factor pathway inhibitor (h-rTFPI) in rabbits: a complex formation of h-rTFPI with factor Xa promotes a clearance rate of h-rTFPI.

  1996cites this paper
• Effect of heparin on the inhibition of factor Xa by tissue factor pathway inhibitor: a segment, Gly212-Phe243, of the third Kunitz domain is a heparin-binding site.

  1995cites this paper
• Recent Progress on Tissue Factor Pathway Inhibitor (TFPI)

  1994cites this paper
• Response of plasma tissue factor pathway inhibitor to diet-induced hypercholesterolemia in crab-eating monkeys.

  1994cites this paper